MediClin AG (XTER:MED) Cyclically Adjusted Revenue per Share: €16.69 (As of Mar. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

XTER:MED MediClin AG XTER:MED
78 GF Score
Price €4.12
GF Value €3.04
Valuation Significantly Overvalued
! 6 Warning Signs
View Full Analysis

What is MediClin AG Cyclically Adjusted Revenue per Share?

MediClin AG XTER:MED +0.49% 78 Cyclically Adjusted Revenue per Share is €16.69 as of Mar. 2026. GuruFocus rates XTER:MED with a GF Score™ of 78/100 and a GF Value™ of €3.04 (Significantly Overvalued). The stock has 6 warning signs investors should review.

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Revenue per Share and the Cyclically Adjusted PS Ratio. The Cyclically Adjusted Revenue per Share is the average of the inflation adjusted Revenue per Share of a company over the past 10 years.

MediClin AG's adjusted revenue per share for the three months ended in Mar. 2026 was €3.707. Add all the adjusted revenue per share for the past 10 years together and divide the count will get our Cyclically Adjusted Revenue per Share, which is €16.69 for the trailing ten years ended in Mar. 2026.

During the past 12 months, MediClin AG's average Cyclically Adjusted Revenue Growth Rate was 3.50% per year. During the past 3 years, the average Cyclically Adjusted Revenue Growth Rate was 3.70% per year. During the past 5 years, the average Cyclically Adjusted Revenue Growth Rate was 5.50% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the Cyclically Adjusted Revenue Growth Rate using Cyclically Adjusted Revenue per Share data.

During the past 13 years, the highest 3-Year average Cyclically Adjusted Revenue Growth Rate of MediClin AG was 6.90% per year. The lowest was 1.90% per year. And the median was 4.40% per year.

As of today (2026-07-24), MediClin AG's current stock price is €4.12. MediClin AG's Cyclically Adjusted Revenue per Share for the quarter that ended in Mar. 2026 was €16.69. MediClin AG's Cyclically Adjusted PS Ratio of today is 0.25.

During the past 13 years, the highest Cyclically Adjusted PS Ratio of MediClin AG was 0.56. The lowest was 0.15. And the median was 0.28.


MediClin AG  (XTER:MED) Cyclically Adjusted Revenue per Share Explanation

If a company grows much fast than inflation, Cyclically Adjusted Revenue per Share may underestimate the company's revenue. Cyclically Adjusted PS Ratio can seem to be too high even the actual PS Ratio is low.

For the Cyclically Adjusted PS Ratio, the revenue per share of the past 10 years are inflation-adjusted and averaged. The result is used for P/S calculation. Since it looks at the average over the last 10 years, the Cyclically Adjusted PS Ratio is also called CAPS Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller. He uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings per share of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PS Ratio. The Cyclically Adjusted Revenue per Share is the average of the inflation adjusted revenue per share of a company over the past 10 years.

MediClin AG's Cyclically Adjusted PS Ratio of today is calculated as

Cyclically Adjusted PS Ratio=Share Price/Cyclically Adjusted Revenue per Share
=4.12/16.69
=0.25

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

During the past 13 years, the highest Cyclically Adjusted PS Ratio of MediClin AG was 0.56. The lowest was 0.15. And the median was 0.28.


Be Aware

Cyclically Adjusted PS Ratio works better for cyclical companies. It gives you a better idea on the company's real revenue value.


MediClin AG Cyclically Adjusted Revenue per Share Related Terms


MediClin AG Cyclically Adjusted Revenue per Share Historical Data

* Premium members only.

The historical data trend for MediClin AG's Cyclically Adjusted Revenue per Share can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

MediClin AG Cyclically Adjusted Revenue per Share Chart

MediClin AG Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Cyclically Adjusted Revenue per Share
Get a 7-Day Free Trial Premium Member Only Premium Member Only 13.48 14.76 15.48 16.04 16.47

MediClin AG Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Cyclically Adjusted Revenue per Share Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 16.13 16.25 16.42 16.47 16.69

XTER:MED vs HCA, THC, DVA: Cyclically Adjusted Revenue per Share Comparison

For the Medical Care Facilities subindustry, MediClin AG's Cyclically Adjusted PS Ratio, along with its competitors' market caps and Cyclically Adjusted PS Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


MediClin AG Cyclically Adjusted PS Ratio vs Healthcare Providers & Services Industry

For the Healthcare Providers & Services industry and Healthcare sector, MediClin AG's Cyclically Adjusted PS Ratio distribution charts can be found below:

* The bar in red indicates where MediClin AG's Cyclically Adjusted PS Ratio falls into.


XTER:MED
78GF Score
MediClin AG XTER:MED
Cyclically Adjusted Revenue per Share is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

MediClin AG Cyclically Adjusted Revenue per Share Calculation

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Revenue per Share and the Cyclically Adjusted PS Ratio. The Cyclically Adjusted Revenue per Share is the average of the inflation adjusted Revenue per Share of a company over the past 10 years.

What is Cyclically Adjusted Revenue per Share? How do we calculate Cyclically Adjusted Revenue per Share?

Cyclically Adjusted Revenue per Share is the average of the inflation adjusted Revenue per Share of a company over the past 10 years. Let's use an example to explain.

If we want to calculate the Cyclically Adjusted Revenue per Share of Wal-Mart (WMT) for Dec. 31, 2010, we need to have the inflation data and the revenue per share from 2001 through 2010.

We adjusted the 2001 revenue per share data with the total inflation from 2001 through 2010 to the equivalent revenue in 2010. If the total inflation from 2001 to 2010 is 40%, and Wal-Mart's revenue is $1 a share in 2001, then the 2001's equivalent revenue in 2010 is $1.4 a share. If Wal-Mart's revenue is $1 again in 2002, and the total inflation from 2002 through 2010 is 35%, then the equivalent 2002 revenue in 2010 is $1.35. So on and so forth, you get the equivalent revenue per share of past 10 years. Then you add them together and divided the sum by the count to get Cyclically Adjusted Revenue per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.

For example, MediClin AG's adjusted Revenue per Share data for the three months ended in Mar. 2026 was:

Adj_RevenuePerShare= Revenue per Share /CPI of Mar. 2026 (Change)*Current CPI (Mar. 2026)
=3.707/131.2583*131.2583
=3.707

Current CPI (Mar. 2026) = 131.2583.

MediClin AG Quarterly Data

Revenue per Share CPI Adj_RevenuePerShare
201606 3.101 100.717 4.041
201609 3.074 101.017 3.994
201612 3.055 101.217 3.962
201703 3.544 101.417 4.587
201706 3.284 102.117 4.221
201709 3.237 102.717 4.136
201712 3.294 102.617 4.213
201803 3.324 102.917 4.239
201806 3.418 104.017 4.313
201809 3.296 104.718 4.131
201812 3.194 104.217 4.023
201903 3.692 104.217 4.650
201906 4.078 105.718 5.063
201909 2.407 106.018 2.980
201912 3.664 105.818 4.545
202003 3.599 105.718 4.468
202006 3.176 106.618 3.910
202009 3.325 105.818 4.124
202012 3.881 105.518 4.828
202103 3.229 107.518 3.942
202106 3.361 108.486 4.067
202109 3.496 109.435 4.193
202112 3.850 110.384 4.578
202203 3.668 113.968 4.224
202206 3.825 115.760 4.337
202209 3.235 118.818 3.574
202212 3.964 119.345 4.360
202303 3.666 122.402 3.931
202306 3.919 123.140 4.177
202309 3.817 124.195 4.034
202312 3.909 123.773 4.145
202403 3.976 125.038 4.174
202406 3.655 125.882 3.811
202409 4.005 126.198 4.166
202412 4.157 127.041 4.295
202503 3.724 127.779 3.825
202506 4.028 128.412 4.117
202509 4.516 129.255 4.586
202512 4.127 129.361 4.188
202603 3.707 131.258 3.707

Add all the adjusted revenue per share together and divide 10 will get our Cyclically Adjusted Revenue per Share.

What does a Cyclically Adjusted Revenue per Share of €16.69 mean?
MediClin AG (XTER:MED) has a Cyclically Adjusted Revenue per Share of €16.69 as of Mar. 2026. Cyclically adjusted revenue per share represents the company's inflation-adjusted revenue per share over a 10-year period. View historical data on MediClin AG and its competitors.
Is MediClin AG's Cyclically Adjusted Revenue per Share too high?
MediClin AG's current Cyclically Adjusted Revenue per Share is €16.69. Overall, MediClin AG has a GF Score™ of 78/100 and is considered Significantly Overvalued, reflecting its overall financial health beyond just this single metric.
How does MediClin AG's Cyclically Adjusted Revenue per Share compare to HCA and THC?
MediClin AG's Cyclically Adjusted Revenue per Share of €16.69 can be compared against companies in the Healthcare Providers & Services industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Cyclically Adjusted Revenue per Share for a Healthcare Providers & Services company?
A good Cyclically Adjusted Revenue per Share depends on the Healthcare Providers & Services industry context. However, Cyclically Adjusted Revenue per Share should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Cyclically Adjusted Revenue per Share mean?
A high Cyclically Adjusted Revenue per Share can signal that a stock is expensive relative to its fundamentals. Cyclically adjusted revenue per share represents the company's inflation-adjusted revenue per share over a 10-year period. View historical data on MediClin AG and its competitors. MediClin AG's current Cyclically Adjusted Revenue per Share is €16.69. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is MediClin AG stock overvalued right now?
Based on GuruFocus' analysis, MediClin AG (XTER:MED) is currently considered Significantly Overvalued. The stock's GF Value™ is €3.04, compared to a current price of €4.12 — trading 35.5% above its estimated fair value. The current Cyclically Adjusted Revenue per Share is €16.69. MediClin AG's overall GF Score™ is 78/100 with 6 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Cyclically Adjusted Revenue per Share calculated?
Cyclically Adjusted Revenue per Share is calculated from a company's financial statements. For MediClin AG (XTER:MED), the current Cyclically Adjusted Revenue per Share is €16.69 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is MediClin AG (XTER:MED) Overvalued in 2026?

Based on GuruFocus' analysis, MediClin AG stock appears to be overvalued. The current stock price of €4.12 is trading 35.5% above its estimated GF Value™ of €3.04. GuruFocus considers MediClin AG to be Significantly Overvalued.

Key valuation signals for XTER:MED:

  • Cyclically Adjusted Revenue per Share: €16.69
  • GF Value™: €3.04 vs. price of €4.12 (35.5% above fair value)
  • GF Score™: 78/100 with 6 warning signs

No single metric tells the full story. See the XTER:MED stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


MediClin AG Business Description

Other Exchanges 0NDG:UK
Address Okenstrasse 27, Offenburg, BW, DEU, 77652
MediClin AG operates hospitals and other medical care centers. The company's reportable operating segments are the Post-acute, Acute, Nursing care, and Service segments. A majority of its revenue is generated from the Post-acute segment, which offers services in the fields of follow-up rehabilitation treatment and curative treatment. Some of the post-acute hospitals also offer services in acute neurology and acute psychosomatics. The Acute segment encompasses medical offerings with a focus on neurology and neurological early rehabilitation as well as psychosomatic medicine, psychiatry, orthopaedics, and internal medicine. The Nursing care segment offers full-time and part-time nursing care as well as daycare, and the Service segment consists of the central services.
78GF Score

Get the complete analysis for XTER:MED

Cyclically Adjusted Revenue per Share is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€4.12
Price
€3.04
GF Value